celecoxib and fh535
celecoxib has been researched along with fh535 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Da, L; Feng, D; Jiang, F; Li, M; Xu, L; Yang, X; Yin, R; Zhang, S; Zhang, Z | 1 |
Other Studies
1 other study(ies) available for celecoxib and fh535
| Article | Year |
|---|---|
Celecoxib potentially inhibits metastasis of lung cancer promoted by surgery in mice, via suppression of the PGE2-modulated β-catenin pathway.
Topics: Animals; Antigens, CD; beta Catenin; Cadherins; Celecoxib; Cell Line, Tumor; Cell Proliferation; Dinoprostone; Down-Regulation; Female; Gene Deletion; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Phosphorylation; Pyrazoles; RNA, Messenger; RNA, Small Interfering; Sulfonamides; Up-Regulation | 2014 |